Latest filing published 07 Feb 2006 for SGX PHARMACEUTICALS, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Atlas Venture Fund IV, L.P.: trading record in brief
Atlas Venture Fund IV, L.P. discloses dealings in SGX Pharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 1 February 2006 to 6 February 2006.
Every open-market trade on record is a purchase: 1 purchase worth €2.1M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 7 February 2006 with a transaction in SGX Pharmaceuticals, Inc. The clock since the last published purchase (3 February 2006) now reads 7,584 days. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Atlas Venture Fund IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,068,402 sharesCommon StockSEC:0001209191-06-008505:0
- 416,666 shares@ US$6.00Common StockSEC:0001209191-06-007534:0Canonical exit: 2 May 2006 (T+90)
2 of 2 declarations
